Dr. David Eisenman and Kirsten Schwarz, both professors at the UCLA Fielding School of Public Health, study the public health ...
While some research has shown benefits for patients who qualify, questions remain about the therapy's long-term risks and use among men without a medical need.
The Pentagon's new testosterone screening policy will test troops over 30. A doctor explains what the research shows about ...
Sonam Wangchuk has been shifted to Safdarjung Hospital and is said to be stable after a 21-day hunger strike, highlighting ...
Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...
Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist Dimerix Limited (ASX: DXB)Mission will receive up to U ...
Dimerix has bought an acute kidney injury (AKI) drug from Mission Therapeutics, paying (PDF) $5 million upfront and ...
Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist ...
Dimerix expands kidney pipeline with DMX-652 acquisition; Phase 2-ready AKI therapy targets US$3.5b market, upfront US$5m ...
Learn more about whether ADMA Biologics, Inc. or CareDx, Inc. is a better investment based on AAII's A+ Investor grades, ...
Learn more about whether ACADIA Pharmaceuticals Inc. or CareDx, Inc. is a better investment based on AAII's A+ Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results